Endovascular Today

Reverse Medical Receives CE Mark Approval for MVP Micro Vascular Plug

May 14, 2013—Reverse Medical Corporation (Irvine, CA) announced that the company’s MVP microvascular plug system for peripheral artery embolization has been granted CE Mark approval to obstruct or reduce the rate of blood flow in the peripheral vasculature.

St. Jude Medical Begins EnligHTN III Study for Next-Generation Renal Denervation System

May 14, 2013—St. Jude Medical, Inc. (St. Paul, MN) announced the commencement of enrollment in the EnligHTN III trial that will evaluate the safety and performance of the company’s second-generation EnligHTN renal denervation system in patients with drug-resistant, uncontrolled hypertension.

CREST Substudy Finds Balloon Angioplasty After Carotid Stenting Reduces Restenosis Risk

May 9, 2013—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of a CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) substudy at the SCAI 2013 scientific sessions in Orlando, Florida. The objective of this substudy was to evaluate whether undergoing angioplasty after carotid stenting increases the risk of complications such as stroke.

Statistical Analysis Supports Renal Denervation for Treating Hypertension Across Age Groups

May 9, 2013—The Society of Cardiovascular Angiography and Interventions (SCAI) announced the presentation of data suggesting that catheter-based renal denervation is projected to improve blood pressure and substantially reduce the incidence of major cardiovascular events in patients whose high blood pressure has not been sufficiently lowered with medications. Lead Investigator Jan Pietzsch, PhD, presented the findings at the SCAI 2013 scientific sessions in Orlando, Florida.

News